IntelliSyn

IntelliSyn is one of the leading independent drug development support providers in North America. The company was founded by members of the AstraZeneca leadership team after the closure of the Montreal facility. Our experienced scientists have a deep understanding of all aspects of medicinal chemistry and possess the expertise to accelerate the discovery of clinically viable drugs while minimizing the risks associated with candidate compounds.